Article Information
History
- February 15, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Giulia Lamacchia1,*,
- Alessio Mazzoni1,*,
- Michele Spinicci1,2,
- Anna Vanni1,
- Lorenzo Salvati1,
- Benedetta Peruzzi3,
- Sara Bencini3,
- Manuela Capone1,
- Alberto Carnasciali1,
- Parham Farahvachi1,
- Arianna Rocca1,
- Seble Tekle Kiros1,
- Lucia Graziani1,
- Lorenzo Zammarchi1,2,
- Jessica Mencarini2,
- Maria Grazia Colao4,
- Roberto Caporale3,
- Francesco Liotta1,3,5,
- Lorenzo Cosmi1,5,
- Gian Maria Rossolini1,4,
- Alessandro Bartoloni1,2,
- Laura Maggi1,# and
- Francesco Annunziato1,3,#,†
- 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
- 2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
- 3Flow cytometry diagnostic center and immunotherapy, Careggi University Hospital, Florence, Italy
- 4Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy
- 5Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy
- ↵†Co-Corresponding authors:
Prof. Francesco Annunziato, Department of Experimental and Clinical Medicine, University of Florence, Viale Pieraccini, 6, 50134 - Firenze (Italy), e-mail: francesco.annunziato{at}unifi.it
Posted February 15, 2022.
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
